Cambridge Investment Research Advisors
INVA icon

Cambridge Investment Research Advisors’s Innoviva INVA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-94,983
Closed -$1.1M – 3160
2022
Q3 		$1.1M Buy
+94,983
New +$1.3M 0.01% 1409

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cambridge Investment Research Advisors's INVA Position: Q4 2022 in Review

Cambridge Investment Research Advisors sold out of Innoviva (INVA) in Q4 2022, closing a stake of 94,983 shares — an estimated $1.1M sold.

Cambridge Investment Research Advisors first reported a position in INVA in Q3 2022 and held it in 1 quarter. The position peaked at $1.1M in Q3 2022. 209 funds tracked by Wall St. Rank hold INVA as of Q4 2022.

  • Cambridge Investment Research Advisors reported no remaining Innoviva position as of Q4 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 94,983 Innoviva shares in Q4 2022, an estimated $1.1M.
  • Cambridge Investment Research Advisors first reported a position in Innoviva in Q3 2022 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Innoviva position peaked at $1.1M in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Innoviva as of Q4 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.